RAYDEL HDL Research Institute
RAYDEL HDL Institute began through research on lipoproteins.
The purpose of RAYDEL HDL Research Institute is to focus on dedicatedresearch on HDL, high-density lipoprotein.
RAYDEL HDL Research Institute conducts its studies based on fundamental science thatexplores lipoproteins, grounded in the safety and scientific verification of theingredients and products that RAYDEL considers most important.
Since 2014, RAYDEL HDL Research Institute has beenconcentrating intensively on HDL research.
Greetings,
I am Kyung-Hyun Cho, Director of the RAYDEL HDL Research Institute.
Our mission is simple to use science to improve health and well-being.
After two decades as a researcher and professor, I realized research shoulddirectly benefit people. This led me to partner with RAYDEL and focus onHDL (high-density lipoprotein) research.
The Institute now conducts clinical studies, animal experiments,biochemistry, and histological analysis. We are the only facility in SouthKorea that can directly visualize HDL particles with electron microscopy.
In the past three years, we have published over 50 SCI-indexed papers andregistered 2 international and 10 domestic patents. We remain committed toadvancing HDL research and improving human health.
We sincerely appreciate your support.
Key Research Areas
Dr. Kyung-Hyun Cho has devoted his career to the in-depth study of lipoproteins. His primary research focuses on lipoprotein metabolism, particularly the structure and functions of low-density lipoproteins (LDL) and high-density lipoproteins (HDL), which are responsible for transporting cholesterol and triglycerides in the bloodstream. His work also includes the reconstitution and functional evaluation of lipoproteins.Building on these foundations, he is actively engaged in the development of new medications and functional foods for the treatment of hypertension, hyperlipidaemia, diabetic complications, and Alzheimer’s disease by inhibiting modifications of lipoproteins such as glycation and oxidation.
Biography
Dr. Kyung-Hyun Cho graduated from the Department of Genetic Engineering at Kyungpook National University. He then completed his postdoctoral training at the University of Illinois College of Medicine at Urbana–Champaign and served as a research doctor at the Cleveland Clinic Foundation until 2002.After returning to South Korea, he worked as a senior researcher at the Korea Research Institute of Bioscience and Biotechnology for four years. In 2005, he joined Yeungnam University as a faculty member in the Department of Biotechnology/ Medical Biotechnology, where he worked as an assistant professor, associate professor, and professor. During his tenure, he also led the Protein Sensor Laboratory and directed the BK21+ Biomedical Serum Research Team.He is currently serving as the director of the RAYDEL HDL Research Institute, which he established within the Daegu-Gyeongbuk High-tech Medical Complex.
Research Achievements
Over the past 33 years, Dr. Kyung-Hyun Cho has published 164 papers in SCI-level journals in the field of HDL research and filed and registered 62 domestic and international patents. He has been invited as a keynote speaker and presenter at numerous international conferences. He currently serves as a guest editor for the international journals Molecules and IJMS, overseeing special issues on HDL metabolism and function. He is also a member of the editorial boards of Atherosclerosis Plus and the International Journal of Environmental Research and Public Health (IJERPH).